Latest News
Latest News
First Non-Prescription Continuous Glucose Monitor Launches
The first OTC CGM for people with T2D who don’t use insulin or who have prediabetes is available for $99 a month.
Latest News
We Asked 7 Doctors: How Do You Get Patients to Exercise?
Make starting easy, recommend doing something they enjoy, point out multiple benefits, and monitor progress.
Latest News
Untreated Hypertension Tied to Alzheimer’s Disease Risk
“These results suggest that treating high blood pressure as a person ages continues to be a crucial factor in reducing their risk of Alzheimer’s...
Latest News
Physicians Lament Over Reliance on Relative Value Units: Survey
“The current RVU system encourages unnecessary procedures, hurting patients.”
From the Journals
Patients With Immune-Mediated Inflammatory Diseases, Type 2 Diabetes Reap GLP-1 Receptor Agonist Benefits, Too
GLP-1 RAs were associated with a decreased risk for all-cause mortality and major adverse cardiovascular events in patients with immune-mediated...
Latest News
Which Medications Can Cause Edema?
Nitrates, calclium channel blockers, neuropathic pain medications, and others can lead to edema.
Latest News
Could Adipose Tissue Be a Better Measure for Obesity Than BMI?
BMI cutoffs are based primarily on mortality data collected from large non-Hispanic White populations, without data on potential differences by...
Latest News
Private Equity in Medicine: Cardiology in the Crosshairs
Private equity firms’ goal is to turn a profit for institutional investors over a 3- to 7-year time horizon.
Feature
Doctors Are Seeking Professional Coaches More Often. Here’s Why
More and more doctors are using professional coaching to manage life in medicine. The coaches, also physicians, say it might be a cure for burnout...
Latest News
Research Could Bring ‘New Era’ in Insulin
Six new research projects aim to improve insulin therapy, helping patients with T1D to better manage their disease.
Commentary
What Every Provider Should Know About Type 1 Diabetes
Patients with T1D are more insulin sensitive than those with type 2 and more prone to both hyper- and hypoglycemia.